Category: Tech IPO

FB Nasdaq FB Facebook
Finance, Tech IPO

Deutsche Bank Announces Capital Raise, Previews 1Q Earnings

It has been long said that Deutsche Bank looks undercapitalized, so it was no surprise today when the bank announced plans to raise EUR 2.8 billion of fresh equity capital through private placements. It plans to issue as many as 90 million new shares, which imply an issuance price of EUR 31.11. At the same time, the bank gave a brief overview of its better-than-expected … Continue reading Deutsche Bank Announces Capital Raise, Previews 1Q Earnings

Colin PettisLeave a comment
Diversified Tech, Finance, Financial, Mergers & Acquisitions, Services Sector, Software, Tech IPO

KPN Meets Street Expectations in Third Quarter

KPN reported third-quarter results that were generally in line with our expectations, and we are maintaining our fair value estimate and moat rating for now. While the firm has chosen to classify E-Plus, the German operation it agreed to sell to Telefonica, as a discontinued operation, we are including the division as we think there is still a significant chance that European regulators will not … Continue reading KPN Meets Street Expectations in Third Quarter

Jason KnoxLeave a comment
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Still-Weak European Paper Demand Weighed on UPM’s 1Q Results

Despite relatively steady performance from the energy and pulp segments, UPM’s quarterly EBITDA contracted 20% year over year; EBITDA from the paper business was nearly halved over the same period. As the world’s largest producer of graphic paper, UPM remains highly dependent on its paper business, where volume continues to decline–European magazine papers fell 6%, newsprint fell 3%, and fine papers fell 6%–and present significant … Continue reading Still-Weak European Paper Demand Weighed on UPM’s 1Q Results

John MeadyLeave a comment
Analysis, BioTech, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Nokia Earnings Show Some Bright Spots

Nokia’s second-quarter earnings report had a couple of bright spots but was mostly concerning as the firm’s mobile phone business continues to languish.  The favorable view of Nokia’s pending acquisition of the remainder of its Nokia Siemens Networks (NSN) joint venture is mostly offset by a rapidly deteriorating basic phone market and only modest Windows Lumia phone adoption to date. Nokia sold 7.4 million Lumia … Continue reading Nokia Earnings Show Some Bright Spots

John BellichLeave a comment
Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

MAT Adapting to Consumers

Mattel MAT continues to adapt to children’s demands, innovating new products tailored to changing tastes. With a number of new franchises coming on line in 2013 (including Ever After High and Max Steel), the company will maintain the wide brand recognition it has captured over numerous decades, keeping its narrow rating intact. While second-quarter results fell short of expectations,  the rest of the year will … Continue reading MAT Adapting to Consumers

Adam KeintzelLeave a comment
Analysis, BioTech, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Smith & Nephew Counters Soft 1Q Reconstructive Sales with Strength in Wound Management

Smith & Nephew SNN posted first-quarter results that were largely consistent with our expectations, and we are standing behind our fair value estimate of $58 per share. As we had suspected, the growth of reconstructive products slowed considerably as Smith & Nephew’s new product cycle is waning just as competitors are launching new products. Nonetheless, the firm plans to launch its new knee system later … Continue reading Smith & Nephew Counters Soft 1Q Reconstructive Sales with Strength in Wound Management

John MeadyLeave a comment